| The cyclophilin inhibitor DEBIO-025 has a potent dual anti-HIV and anti-HCV activity in treatment-naïve HIV/HCV co-infected subjects |
|
R. Flisiak, A. Horban, J. Kierkus, J. Stanczak, I. Cielniak, GP Stanczak, A Wiercinska-Drapalo, E. Siwak, J. Higersberger, C. Aeschlimann, P. Grosgurin, V. Nicolas, J-M Dumont, H. Porchet, R. Crabbé, P. Scalfaro* American Association for the Study of Liver Diseases (AASLD) - Oct 27-31, 2006 - Boston/USA |
Poster